Bioiberica celebrates its 50th anniversary at CPHI 2025 with a new brand identity

Bioiberica celebrates its 50th anniversary at CPHI Worldwide 2025, the world's largest pharmaceutical event, bringing together more than 62,000 professionals and 2,400 exhibitors from 170 countries. The fair, held from October 28-30 in Frankfurt (Germany), marks 35 years of connecting the global pharmaceutical community and presenting the latest innovations across the entire supply chain: from ingredients and APIs to machinery, bioproduction, dosage forms, and packaging.

In this international benchmark context, Bioiberica marks a historic milestone with the launch of a renewed brand identity and a new website. This strategic rebranding culminates half a century of dedication to advancing the health and well-being of people, animals, and plants—a commitment that began with the manufacturing of its world-reference Heparin API.

A New Identity for a Healthier Future

The new brand image reflects Bioiberica's continued commitment to life sciences and presents a renewed corporate purpose: "For a healthier, safer world", along with a new tagline, "We are all one", which underscores the collaborative approach and "One Health" concept that guides the company.

Heparin: Where It All Began

Since its founding in Palafolls (Barcelona) in 1975, Bioiberica has been a pioneer in the research, production, and commercialization of biomolecules of natural origin. This 50th anniversary commemorates five decades of industry leadership, driven by a collaborative approach to science and a commitment to sustainable, high-quality progress.

At CPHI, Bioiberica will highlight its position among the world's leading heparin producers, an essential antithrombotic molecule that saves more than 100 million lives per year. With unparalleled experience in this area, the company offers customized processes and formulations in its specialized heparin portfolio, adapting to the specific needs and applications of its clients.

Innovation and Global R&D Collaboration

"We continue to champion science and innovation to push the boundaries of heparin research, with more than 40 projects in research centers across 10 countries, working in collaboration with prestigious institutions such as the G. Ronzoni Institute, King's College London, and other innovative medical technology companies," comments Javier Velasco, R&D Director at Bioiberica.

"This continuous investment in research is vital to address global health challenges such as thrombosis, which is estimated to cause 1 in 4 deaths worldwide, and to advance complex projects ranging from anticoagulant devices to next-generation ophthalmic treatments," notes the Bioiberica executive.

A Complete Portfolio for Global Health

In addition to Heparin API, Bioiberica offers a broad portfolio of APIs of biological origin, including Thyroid, Chondroitin sulfate, and Glucosamine. Visitors to booth 12.0D30 will also have the opportunity to explore Bioiberica's flagship nutraceutical ingredients, such as Collavant n2 and Mobilee for mobility, Dermial for skin health, and DAOgest for histamine intolerance.

• Attendees will be among the first to try a pioneering "collagen milk" with Collavant n2, native (undenatured) type II collagen, at the booth's "Coffee Corner."

Commitment to Excellence

"We want to celebrate our 50th anniversary and share our renewed visual identity with our partners at CPHI, as we begin the next chapter of our mission to drive the evolution of health," comments Luis Solera, CEO of Bioiberica. "The rebranding underscores our commitment to life sciences and the dedication of our team, comprised of more than 500 professionals operating in nine global production centers, to deliver a portfolio of more than 100 products through a vertically integrated supply chain (as part of the SARIA Group) to more than 80 countries. For 50 years, innovation has been our compass, and looking to the future, we remain dedicated to advancing and shaping a healthier and safer world for all," summarizes the CEO of Bioiberica.

Quality and Safety: A Permanent Commitment

Quality and safety are inherent to Bioiberica's history and the manufacturing of high-value ingredients of biological origin. The company guarantees maximum traceability, quality, and safety at every stage of product development thanks to the reliability of its processes and protocols developed over 50 years, including its unique circular economy model and vertical integration as part of the SARIA Group. This allows Bioiberica to offer products of excellence that meet the most demanding standards in the pharmaceutical, veterinary, agricultural, and nutraceutical sectors.

• The Bioiberica team will be present at booth 12.0D30 (API area) at CPHI Worldwide 2025, Frankfurt, from October 28-30, 2025.